# John Kumar Jain MD Inc. – FDA Inspection, Feb 8, 2019

Source: https://www.keypedia.com/records/fda_inspections/john-kumar-jain-md-inc/c0ec8beb-2399-43ec-ae54-459796af664a
Source feed: FDA_Inspections

> FDA inspection 1079897 of John Kumar Jain MD Inc., February 08, 2019. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1079897
- Company Name: John Kumar Jain MD Inc.
- Inspection Date: 2019-02-08
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1222754 - 2023-11-02
- FDA Inspection 987194 - 2016-09-23
- FDA Inspection 795837 - 2012-08-20
- [FDA Inspection 611636 - 2009-09-02](https://www.keypedia.com/records/fda_inspections/john-kumar-jain-md-inc/9e12fbdf-fab6-440c-9757-5d7d4a16162b)

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/laurissa-s-flowers/27453525-c2fc-4a05-9cdc-7a1ed884304f)

Company: https://www.keypedia.com/companies/john-kumar-jain-md-inc/cf1a0277-6c8a-4c55-9df7-91c473fef357

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
